Controlled & Reproducible Crystallisation

Exalt is a proprietary technology developed by Genevac with partners in the field of pharmaceutical small molecule crystallisation. Exalt enables a wide range of solvents to be evaporated at the same time, and all at the same slow rate and is used for polymorph screening and stable form identification. To download a review undertaken by Novartis Pharmaceuticals in which results are presented for several studies covering Polymorph and Co-crystal screening, displacement of hydrates, as well as evaluation of Exalt using commercially available compounds please click here.